NCT07598695

Brief Summary

The following experiment will be conducted with 15 chronic stroke survivors and 15 control subjects. Subjects will perform hand movements in the virtual reality environment using a head-mounted display. Quest's onboard cameras allow real-time tracking of hand motion, estimating joint angles of the finger and the thumb. For each feedback manipulation condition (i.e., movement amplification or reduction), the estimated joint angles will be multiplied by a factor greater than 1 (amplification) or a factor smaller than 1 (reduction). Then the newly-estimated hand posture will be displayed in the VR environment. Subjects will be randomly assigned into two groups (A and B), who will receive the assistance in a different order. Subjects will perform finger extension under three conditions: no sensory modulation, movement visual feedback (VF) amplification, and movement VF reduction (error augmentation), while their movement muscle activation patterns are recorded.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P50-P75 for early_phase_1 stroke

Timeline
7mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Oct 2025Dec 2026

Study Start

First participant enrolled

October 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 5, 2026

Last Update Submit

May 13, 2026

Conditions

Keywords

StrokeMuscle coordinationVisual feedbackHand

Outcome Measures

Primary Outcomes (1)

  • Joint range of motion (ROM)

    range of motion of individual finger joints under each condition, measured by embedded cameras that digitize individual finger segments

    Periprocedural

Secondary Outcomes (1)

  • Muscle activation

    Periprocedural

Study Arms (2)

Visual ROM augmentation followed by visual ROM reduction

EXPERIMENTAL
Device: Visual ROM augmentationDevice: Visual ROM reduction

Visual ROM reduction followed by visual ROM augmentation

EXPERIMENTAL
Device: Visual ROM augmentationDevice: Visual ROM reduction

Interventions

Finger joint ROM is amplified.

Visual ROM augmentation followed by visual ROM reductionVisual ROM reduction followed by visual ROM augmentation

Visual feedback of finger joint ROM is reduced.

Visual ROM augmentation followed by visual ROM reductionVisual ROM reduction followed by visual ROM augmentation

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18 - 70 years old
  • First-ever unilateral cortical stroke with resultant hemiparesis at least 6 months prior to the experimental testing
  • Fugl-Meyer Upper Extremity Section 31 - 55

You may not qualify if:

  • Presence of concurrent severe medical illness
  • Pain in hand or arm with movements
  • Loss of voluntary control of fingers and thumb
  • Inability to provide informed consent
  • Musculoskeletal injuries (e.g., fracture) or medical complications (e.g., severe cardiovascular disease).
  • Healthy Group:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic University of America

Washington D.C., District of Columbia, 20064, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Sang Wook Lee, PhD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 20, 2026

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

We do not plan to share IPD but the de-identified data will be shared.

Locations